N/A
N=978
Health Education Model Led by Community Health Volunteers.
Schistosomiasis · Health Education
Bottom Line
View on ClinicalTrials.gov: NCT06312462 ↗Enrolled (actual)
978
Serious AEs
0.0%
Results posted
Oct 2025
Primary outcome: Primary: Change in Infection Rate — 47; 35; 3; 6 Number of Participants with S. haematobi
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- health education (Behavioral)
- Age
- Pediatric · 7+ yrs
- Sex
- All
- Sponsor
- Pemba Ministry of Health Zanzibar
- Primary completion
- Feb 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Infection Rate |
47; 35; 3; 6; 4; 3 | — |
| PRIMARY Change in Knowledge Scores |
6.11; 6.42; 6.27; 7.13; 6.62; 7.22 | — |
| PRIMARY Attitudes Changes |
38.02; 39.06; 39.37; 41.2; 41.24; 42.55 | — |
| PRIMARY Behaviors Changes |
19.05; 19.35; 19.43; 20.56; 20.25; 19.77 | — |
Summary
The goal of this intervention study is to investigate the level of knowledge, attitudes, and behaviors of students on schistosomiasis in Pemba Island. It aims to test the effectiveness of establishing a widely applicable Community Health Volunteers model in the Zanzibar region and explore the feasibility of promoting this model in other areas of Africa. This study also aims to provide valuable insights and references for global schistosomiasis prevention and control efforts.
Eligibility Criteria
Inclusion Criteria
- Individuals whose grades fall within the scope of the survey Students who have not received health education intervention on schistosomiasis conducted by community health volunteers Students or parents who agree to sign informed consent and participate in the study Students residing in schistosomiasis-endemic areas
Exclusion Criteria
- Students whose grades are not within the scope of the survey Students who have already received health education intervention on schistosomiasis Students or parents who refuse to sign informed consent or participate in the study Students who have been diagnosed with other serious illnesses.
Data sourced from ClinicalTrials.gov (NCT06312462). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.